What Is Bacterial Artificial Chromosome Fundamentals And Applications

Published

Table of Contents

Bacterial Artificial Chromosomes (BACs) represent a cornerstone of modern molecular biology, offering unparalleled capacity for cloning and manipulating large genomic fragments. Since their development in the late 1980s, BACs have revolutionized genetic research by enabling the stable propagation of inserts exceeding 300 kilobases—a feat unattainable with conventional vectors like plasmids or yeast artificial chromosomes. Their integration into landmark projects, such as the Human Genome Project, underscores their indispensable role in unraveling complex genetic architectures and accelerating biotechnological innovations.

The versatility of BACs stems from their structural elegance, combining the replicative efficiency of bacterial systems with the scalability required for high-throughput genomic studies. Unlike transient cloning platforms, BACs maintain insert integrity through low-copy-number replication and robust partitioning mechanisms, ensuring fidelity during long-term propagation. This stability, coupled with their compatibility with Escherichia coli hosts, positions them as the gold standard for applications ranging from physical genome mapping to synthetic biology pathway engineering.

what is bacterial artificial chromosome

Foundational Concepts and Development of Bacterial Artificial Chromosomes (BACs)

Bacterial Artificial Chromosomes (BACs) represent a pivotal advancement in molecular cloning, enabling the stable propagation of large DNA fragments in bacterial hosts. Their development addressed critical limitations of earlier cloning vectors, such as plasmids and yeast artificial chromosomes (YACs), by combining high insert capacity with ease of manipulation. BACs leverage the F-factor, a low-copy-number plasmid derived from Escherichia coli, to maintain large DNA inserts (up to ~300 kb) with minimal recombination and high fidelity. This stability makes them indispensable for genome sequencing, functional genomics, and synthetic biology applications.

The conceptual foundation of BACs emerged from the need to clone and analyze complex genomic regions that exceeded the capacity of traditional vectors. Early cloning systems, such as plasmids (e.g., pBR322, pUC19) and cosmids (capable of ~45 kb), were insufficient for large-scale genomic projects. The breakthrough came in the late 1980s and early 1990s, with key contributions from scientists like Shigeyuki Kajiwara and Toshio Shizuya, who engineered the first functional BAC vectors by modifying the E. coli F-factor. Their work demonstrated that BACs could maintain inserts of ~100–300 kb with minimal rearrangement, a feat unattainable by other systems at the time. Subsequent refinements, including the development of pBACe3.6 and pCC1BAC, further optimized cloning efficiency and host compatibility.

BACs integrate the stability of bacterial plasmids with the large insert capacity of eukaryotic chromosomes, bridging the gap between high-throughput cloning and functional genomics.

Comparison of BACs with Other Cloning Vectors

The selection of a cloning vector depends on insert size, host organism, and intended application. While plasmids and YACs serve distinct roles, BACs offer a balanced solution for medium-to-large DNA fragments. Below is a comparative analysis of key vector types, highlighting their capacity, host systems, and common applications.
Vector Type Insert Size Capacity (kb) Host Organism Common Applications
Plasmids (e.g., pBR322, pUC19) 5–15 kb E. coli (and other bacteria)
  • Gene cloning and expression
  • Protein production (e.g., recombinant insulin)
  • Basic genetic engineering (e.g., CRISPR guide RNA constructs)
Cosmids (e.g., pWE15, SuperCos) 35–45 kb E. coli (packaged via lambda phage)
  • Genomic library construction
  • Large fragment cloning (e.g., early human genome projects)
  • Gene mapping studies
Yeast Artificial Chromosomes (YACs) 100–2,000 kb (theoretical) Saccharomyces cerevisiae
  • Large-scale genome sequencing (e.g., Human Genome Project)
  • Chromosome walking and mapping
  • Telomere and centromere studies
Bacterial Artificial Chromosomes (BACs) 70–300 kb (stable), up to 1 Mb (unstable) E. coli (low-copy number)
  • Physical mapping of genomes (e.g., Drosophila, Arabidopsis)
  • Functional genomics (e.g., gene knockout libraries)
  • Synthetic biology (e.g., assembling large DNA constructs)
  • Transgenic animal models (e.g., BAC transgenics in mice)
P1 Artificial Chromosomes (PACs) 100–300 kb E. coli (phage P1-derived)
  • High-resolution physical mapping
  • Bacterial artificial chromosome (BAC) validation
The advantages of BACs over YACs include lower recombination rates, simpler manipulation in bacterial hosts, and compatibility with high-throughput screening. Conversely, plasmids and cosmids, while easier to use, lack the capacity for large-insert cloning. YACs, despite their potential for enormous inserts, suffer from chromosomal instability and high recombination, making them less practical for routine applications. BACs thus occupy a unique niche, particularly in genome sequencing projects (e.g., the C. elegans and Arabidopsis genomes) and functional genomics, where stability and scalability are paramount.

Mechanisms Underlying BAC Stability and Functionality

The stability of BACs stems from three interconnected features: low copy number, efficient partitioning during cell division, and minimal recombination. The F-factor origin of replication (oriS) ensures that BACs are maintained at 1–2 copies per cell, reducing metabolic burden and insert instability. Additionally, the parA/parB partitioning system, derived from the F-factor, actively segregates BACs to daughter cells, preventing loss during bacterial division.

Recombination suppression in BACs is achieved through:

  • Host strain selection: Use of E. coli strains deficient in recombination (e.g., DH10B, DH5α), which lack functional recA or recBCD pathways.
  • Vector design: Incorporation of antibiotic resistance markers and selectable origins to maintain plasmid integrity.
  • Insert size constraints: While BACs can theoretically accommodate >1 Mb, inserts exceeding ~300 kb often exhibit instability due to recombination hotspots or replication stress.
  • The combination of low-copy replication and recombination-deficient hosts enables BACs to maintain large inserts with >99% fidelity over hundreds of generations.
    For applications requiring ultra-stable clones, researchers employ BAC midiprep protocols (e.g., using Qiagen Large-Construct Kit) to minimize shearing and maintain insert integrity. Advances in BAC transposition systems (e.g., Cre-loxP or FRT/FLP) further enable precise manipulation of inserts without recombination artifacts.

    Structural and Functional Components of Bacterial Artificial Chromosomes (BACs)

    Bacterial artificial chromosomes (BACs) represent a sophisticated cloning platform designed to accommodate large DNA fragments while ensuring genetic stability and efficient propagation in bacterial hosts. Their structural design integrates elements from both bacterial and eukaryotic chromosomes, enabling high-fidelity replication and maintenance within Escherichia coli. The functional advantages of BACs—such as their ability to stabilize inserts exceeding 300 kb and their compatibility with genomic-scale cloning—stem from their core architectural features, including low-copy replication origins, partitioning systems, and selectable markers. Below, the structural components and mechanisms underlying BAC stability are examined, followed by a comparative analysis of their performance against traditional cloning vectors.

    Core Structural Elements of BAC Vectors

    The foundational architecture of a BAC vector incorporates three critical components that define its functionality: the origin of replication (ori), antibiotic resistance genes (selectable markers), and cloning sites. These elements are derived from the F-factor plasmid of E. coli, which confers stability and controlled replication.

    The origin of replication (ori) in BACs is derived from the F-factor plasmid and is classified as a low-copy-number origin (typically 1–2 copies per cell). This ensures minimal metabolic burden on the host while maintaining sufficient DNA dosage for stable inheritance. The ori sequence includes:

  • Iterons: Binding sites for RNA polymerase and the initiator protein (IHF and Fbp), which regulate replication initiation.
  • RepE gene: Encodes the replication initiator protein, which binds to iterons and controls copy number.
  • Partitioning locus (parA/parB): A system that ensures equal segregation of BACs during cell division, preventing loss in daughter cells.
  • Antibiotic resistance genes serve as selectable markers, typically conferring resistance to chloramphenicol (e.g., cat gene) or kanamycin (e.g., nptII gene). These markers enable the selection of transformed cells and maintenance of the vector under antibiotic pressure. The cat gene is particularly favored in BACs due to its strong expression and compatibility with high-copy-number plasmids during intermediate steps of cloning.

    Cloning sites are strategically positioned within the vector to facilitate insertion of foreign DNA. The most common configuration includes:

  • Multiple cloning site (MCS): A polylinker region containing restriction sites for enzymes such as EcoRI, HindIII, BamHI, and NotI, allowing directional or blunt-end cloning.
  • Flanking regions: Often include cos sites (for lambda phage packaging) or loxP sites (for Cre-lox recombination), enabling downstream applications such as subcloning or transgenesis.
  • Mechanisms of BAC Stability in Bacterial Hosts

    The stability of BACs in E. coli arises from a combination of low copy number, partitioning systems, and host-dependent replication controls. These mechanisms collectively minimize the risk of vector loss or rearrangement during propagation.

    Low Copy Number and Reduced Mutational Pressure
    BACs replicate at a rate of 1–2 copies per cell, which reduces the likelihood of recombination or deletion events that plague high-copy-number vectors (e.g., pUC or pBR322). The F-factor ori imposes strict control over replication initiation, limiting the number of replication forks and thereby lowering the probability of insert instability. Empirical studies demonstrate that inserts larger than 100 kb remain stable in BACs for hundreds of generations, whereas high-copy plasmids often exhibit deletions or rearrangements after 10–20 generations.

    Partitioning Systems: Ensuring Equal Segregation
    The parA/parB locus in BACs encodes a type I partitioning system, analogous to that found in bacterial chromosomes. This system functions as follows:

  • ParB protein binds to specific parS sites flanking the ori and condenses the DNA into a compact structure.
  • ParA protein, an ATP-dependent motor, interacts with ParB-bound DNA and the cell division apparatus to actively segregate BACs to daughter cells.
  • Active partitioning compensates for stochastic distribution during cell division, ensuring that at least one copy of the BAC is retained in each progeny cell.
  • Host Strain Compatibility and Replication Fidelity
    BAC propagation relies on specific E. coli strains optimized for DNA repair and recombination efficiency, such as DH10B or DH5α. These strains express recA and recBCD genes, which enhance homologous recombination and stabilize large inserts. Additionally, the use of dam (DNA adenine methylase-deficient) and dcm (DNA cytosine methylase-deficient) strains further reduces restriction-modification barriers, improving cloning efficiency.

    Functional Advantages of BACs Over Traditional Cloning Vectors

    BACs offer distinct advantages over conventional plasmid vectors (e.g., pUC, pBR322) and yeast artificial chromosomes (YACs), particularly in applications requiring large-scale genomic cloning. Their superior performance is attributed to the following key features:
    • High Insert Stability: BACs maintain inserts up to 350 kb without significant deletions or rearrangements, whereas YACs frequently suffer from chimerism and chromosomal breakage. Plasmid vectors, limited to ~15 kb, are prone to insert truncation due to recombination.
    • Efficient Propagation in E. coli: Unlike YACs, which require specialized yeast strains and media, BACs replicate in standard E. coli cultures with high transformation efficiency (>108 CFU/µg DNA). This simplifies screening and subcloning workflows.
    • Compatibility with Large Genomic Fragments: BACs enable the cloning of entire bacterial genomes (e.g., E. coli O157:H7, ~5.5 Mb) or complex mammalian loci (e.g., human MHC region, ~3.5 Mb). Traditional plasmids cannot accommodate such large inserts due to toxicity and instability.
    • Low Recombination Rates: The low-copy-number replication and partitioning systems suppress homologous recombination, preserving insert integrity during long-term storage or passaging.
    • Versatility in Downstream Applications: BACs support transgenic animal production, BAC transgenesis, and sequencing projects (e.g., Human Genome Project) due to their ability to carry intact genomic regions with minimal artifacts.

    Step-by-Step Assembly of a BAC Vector in a Laboratory Setting

    The construction of a BAC vector involves restriction digestion of the insert and vector, ligation, and transformation into competent cells. Below is a standardized protocol optimized for high-efficiency cloning.

    Preparation of Components
    Prior to assembly, the following materials must be prepared:

  • BAC vector backbone (e.g., pBACe3.6, containing ori, cat, and MCS).
  • Target DNA insert (purified via gel extraction or midiprep).
  • Restriction enzymes (e.g., HindIII and NotI for directional cloning).
  • T4 DNA ligase and ligation buffer (optimized for large fragments).
  • Competent E. coli cells (e.g., DH10B, electrocompetent or chemically competent).
  • Step 1: Restriction Enzyme Digestion
    The vector and insert are digested with compatible restriction enzymes to generate compatible overhangs or blunt ends. For directional cloning:

  • Vector digestion: Incubate 1 µg of BAC vector with HindIII and NotI at 37°C for 2 hours. Heat-inactivate enzymes at 65°C for 20 minutes.
  • Insert digestion: Digest 2–5 µg of target DNA with the same enzymes under identical conditions. Purify digested products using gel extraction (for fragments >5 kb) or PCR purification (for smaller inserts).
  • Dephosphorylation (optional): Treat vector with calf intestinal phosphatase (CIP) to prevent self-ligation, followed by ethanol precipitation.
  • Step 2: Ligation of Insert DNA
    Ligation efficiency is critical for large inserts (>10 kb). Use the following parameters:

  • Vector:Insert ratio: 1:1 to 1:3 (w/w) for inserts <20 kb; 1:1 for larger inserts to minimize multimer formation.
  • Ligation conditions:
  • 1× T4 ligase buffer (50 mM Tris-HCl, 10 mM MgCl₂, 1 mM ATP, 1 mM DTT, pH 7.5).
  • 1 U of T4 DNA ligase per 100 ng of DNA.
  • Incubation at 16°C overnight
  • what is bacterial artificial chromosome - Ilustrasi 2

    Applications of Bacterial Artificial Chromosomes in Genomics and Biotechnology

    Bacterial artificial chromosomes (BACs) have revolutionized genomics and biotechnology by enabling the stable propagation of large DNA fragments, facilitating large-scale genome sequencing, and supporting functional genomics applications. Their capacity to maintain inserts of up to 300 kb with high fidelity makes them indispensable for physical genome mapping, sequencing, and gene manipulation. This section explores their pivotal role in landmark projects, such as the Human Genome Project, their utility in assembling complex genomes, and their distinct contributions to functional genomics and synthetic biology.

    Role of BACs in Large-Scale Genome Sequencing Projects

    BACs were instrumental in the Human Genome Project (HGP), where they served as the backbone for constructing contig maps—overlapping sequences of genomic fragments that collectively represent entire chromosomes. The HGP utilized BAC libraries to:
  • Fragment and clone human genomic DNA into manageable segments (~150–200 kb per clone).
  • Generate high-resolution restriction maps via fingerprinting (e.g., using HindIII or EcoRI enzymes), which allowed alignment of clones based on shared restriction fragments.
  • Enable hierarchical sequencing, where BAC clones were sequenced in parallel, followed by assembly into contiguous sequences (contigs) using bioinformatics tools like Phrap or CAP3.
  • Key Contribution: The BAC-end sequencing (BES) strategy, where the ends of BAC inserts were sequenced, provided anchor points for assembling shotgun sequences into larger scaffolds, reducing gaps and misassemblies in the final genome draft.
    Beyond the HGP, BACs have been employed in sequencing projects for:
  • Model organisms: Drosophila melanogaster, Arabidopsis thaliana, and Mus musculus, where BAC libraries facilitated comparative genomics.
  • Non-model species: Plants (e.g., Oryza sativa rice genome) and pathogens (e.g., Mycobacterium tuberculosis), where large insert clones mitigated challenges posed by repetitive sequences.
  • Metagenomics: BACs have been used to clone and sequence environmental DNA from microbial communities, preserving structural context lost in short-read sequencing.
  • Physical Mapping of Genomes Using BAC Clones

    Physical mapping relies on BACs to generate ordered, overlapping clone libraries that reflect the linear arrangement of genomic regions. The process involves three critical steps:
    1. Library Construction and Screening
      BAC libraries are generated by partially digesting genomic DNA with restriction enzymes (e.g., HindIII, BamHI), ligating fragments into a pBAC vector (e.g., pBeloBAC11), and transforming into E. coli. Libraries are screened using PCR, hybridization (e.g., FISH), or sequence-tagged sites (STSs) to identify clones containing regions of interest.
    2. Fingerprinting and Clone Overlap Identification
      Clones are digested with a four-base cutter (e.g., DdeI or TaqI), and the resulting fragments are separated via pulsed-field gel electrophoresis (PFGE). The banding patterns ("fingerprints") are compared computationally to identify overlaps, typically requiring ≥90% similarity to confirm adjacency.
    3. Contig Assembly and Validation
      Overlapping clones are assembled into contigs using software like FPC (FingerPrinted Contigs) or BAC End Sequence (BES)-based alignment. Validation is achieved through:
      • End-sequencing of BAC inserts to confirm adjacency.
      • Fluorescence in situ hybridization (FISH) to map clones to chromosomes.
      • Sequence alignment with reference genomes (if available).
    Example: The Human Genome Project used BAC contigs to anchor ~30,000 clones per chromosome, achieving an average clone overlap of ~10 kb, which reduced gaps in the final assembly.
    Visualization of BAC-Based Genomic Libraries
    A descriptive illustration for BAC clone libraries should include:
  • Circular or linear maps representing BAC clones, with insert sizes labeled (e.g., 150 kb, 200 kb).
  • Overlap regions highlighted as shaded or dashed connections between adjacent clones, with a scale bar indicating physical distance (e.g., 10 kb increments).
  • Target genomic regions marked as bolded segments within the map, with annotations for:
  • Genes (e.g., BRCA1 in human BACs).
  • Repetitive elements (e.g., Alu sequences) as striped patterns.
  • Sequencing gaps as broken lines between contigs.
  • Color-coding to distinguish:
  • Completed contigs (solid lines).
  • Partial clones (dotted lines).
  • Overlapping regions (intersecting arcs).
  • Comparison of BAC Applications in Functional Genomics and Synthetic Biology

    BACs serve distinct but complementary roles in functional genomics (studying gene function) and synthetic biology (engineering biological systems). Their utility stems from their ability to carry large DNA fragments with minimal rearrangement, though their applications diverge in scope and methodology.
    1. Functional Genomics: Gene Editing and Transgenic Models
      BACs are used to:
      • Preserve genomic context in transgenesis, avoiding positional effects caused by random integration (e.g., in E. coli or mammalian cells). For example:
      • Knock-in/knockout studies: BAC transgenesis in mice (BAC transgenic mice) allows precise manipulation of genes with surrounding regulatory elements (e.g., Hox genes in developmental biology).
      • BAC-based gene traps: Insertional mutagenesis in Drosophila or C. elegans to identify gene function.
      • Facilitate CRISPR-Cas9 targeting: BACs serve as donor templates for homology-directed repair (HDR), enabling:
      • Large-scale gene editing (e.g., correcting DMD mutations in muscular dystrophy models).
      • Epigenetic studies by maintaining native chromatin states during cloning.
    2. Synthetic Biology: Metabolic Engineering and Pathway Reconstruction
      BACs enable the assembly of multi-gene pathways for:
      • Metabolic engineering in microbes:
      • Artificial operons: Cloning entire biosynthetic pathways (e.g., artemisinin production in E. coli or yeast) into BACs to optimize expression.
      • Chassis engineering: Introducing BACs into Pseudomonas putida or Saccharomyces cerevisiae for robust heterologous protein production.
      • Synthetic chromosomes: BACs have been used to construct minimal genomes (e.g., Mycoplasma synthetic chromosomes) or synthetic scaffolds for synthetic biology projects like iGEM.
    Key Difference:
    Functional genomics leverages BACs to retain native genomic architecture for studying gene function in vivo, while synthetic biology exploits BACs to recombine and optimize genetic circuits ex vivo, often with non-native components.
    Table: Comparative Overview of BAC Applications
    Application Domain Primary Use Case Example Projects Advantages of BACs
    Functional Genomics Gene function validation, transgenic models
  • BAC transgenic mice (e.g., Hoxb8 studies)
  • CRISPR-HDR in Drosophila (e.g., Dfd gene editing)
  • Preserves regulatory elements
  • Reduces positional effects
  • Synthetic Biology Metabolic pathway reconstruction, synthetic chromosomes
  • E. coli artemisinin pathway (BAC-based assembly)
  • S. cerevisiae biofuel production
  • Accommodates large, complex pathways
  • Enables stable multi-gene integration
  • BAC Cloning Techniques and Protocols

    Bacterial artificial chromosomes (BACs) serve as high-capacity cloning vectors capable of stably maintaining large DNA inserts (typically 100–300 kb) with minimal rearrangement. The construction of a BAC library involves precise manipulation of genomic DNA to generate large, contiguous fragments suitable for long-term propagation in Escherichia coli. This process integrates enzymatic digestion, size fractionation, vector ligation, and transformation, each step requiring rigorous optimization to ensure fidelity and efficiency. Below, the standard workflow is detailed, alongside challenges and verification strategies critical for library quality control.

    Standard Protocol for Constructing a BAC Library from Genomic DNA

    The construction of a BAC library begins with the partial digestion of high-molecular-weight genomic DNA to generate fragments of the desired size range (100–300 kb). This step is followed by size selection to enrich for large inserts, ligation into a BAC vector containing a bacterial origin of replication and selectable markers, and transformation into a suitable host strain. Each phase must be executed with care to minimize DNA shearing, chimerism, and toxicity-related losses.

    Partial Digestion with Restriction Enzymes
    Genomic DNA is partially digested using a restriction enzyme that recognizes a 6-basepair (6-bp) or 8-bp site, such as BamHI or HindIII, to produce a range of fragment sizes. Partial digestion ensures that not all recognition sites are cleaved, yielding a distribution of fragments suitable for cloning. The reaction is typically performed in a large volume (e.g., 100–200 µL) with enzyme concentrations empirically determined to achieve an average fragment size of 150–200 kb. Blockquote:
    "Optimal enzyme concentration is critical: excessive digestion reduces fragment size, while insufficient digestion yields overly large, difficult-to-clone fragments."

    The reaction is incubated at the enzyme’s optimal temperature (e.g., 37°C for BamHI) for 1–2 hours, followed by heat inactivation (e.g., 65°C for 10 minutes). The use of a buffer system compatible with downstream size selection (e.g., Tris-EDTA or TE buffer) is essential to preserve DNA integrity.

    Size Selection of Large Fragments
    Size fractionation is performed using pulsed-field gel electrophoresis (PFGE) or gradient sucrose sedimentation. PFGE, conducted in a 1% agarose gel with a low-melting-point agarose (e.g., SeaKem GTG) and a CHEF-DR III system (Bio-Rad), separates fragments by size under alternating electric fields. The gel is stained with ethidium bromide, and the region corresponding to 100–300 kb is excised under UV light. Blockquote:
    "Excision should be performed with minimal UV exposure to prevent DNA damage; long-wave UV (365 nm) is preferred."

    For sucrose gradient centrifugation, genomic DNA is layered onto a 10–40% sucrose gradient in TE buffer and centrifuged at 18,000 × g for 16–20 hours. Fractions are collected from the bottom of the gradient, and those containing the target size range are identified by PFGE or agarose gel electrophoresis.

    Ligation into BAC Vectors and Transformation
    BAC vectors, such as pBeloBAC11 or pCC1BAC, contain the f1 origin of replication, a chloramphenicol or kanamycin resistance gene, and lacZα for blue-white screening. The vector is linearized with the same restriction enzyme used for genomic DNA digestion and purified via phenol-chloroform extraction or column-based methods. Ligation is performed using T4 DNA ligase in a high-concentration reaction (e.g., 1–2 µg genomic DNA + 50–100 ng vector) to favor insert-vector junctions. The reaction is incubated overnight at 16°C to maximize ligation efficiency.

    Transformed E. coli cells (e.g., DH10B or DH5α) are plated on LB agar containing chloramphenicol (12.5 µg/mL) and X-gal/IPTG for blue-white screening. White colonies indicate successful recombination, while blue colonies are discarded. Blockquote:
    "Host strain selection is critical: DH10B, with its recA mutation, minimizes recombination artifacts during propagation."

    Common Challenges in BAC Cloning and Mitigation Strategies

    The construction of BAC libraries is hindered by several technical challenges, including chimerism, insert toxicity, and low transformation efficiency. Each issue arises from specific steps in the workflow and requires targeted solutions to ensure library integrity.

    Chimerism and Insert Instability
    Chimerism occurs when two or more non-adjacent genomic fragments are ligated into a single BAC, leading to misrepresentations in the library. This is often caused by incomplete restriction digestion or excessive ligation times. Solutions include:

  • Using high-fidelity restriction enzymes (e.g., BamHI-HF) to ensure complete digestion.
  • Performing short ligation reactions (1–2 hours at 16°C) to reduce concatenation.
  • Employing host strains with recombination deficiencies (e.g., recA mutants) to prevent in vivo recombination.
  • Toxicity of Inserts
    Certain genomic regions, such as those encoding repetitive elements or highly expressed genes, may be toxic to E. coli, leading to reduced transformation efficiency or clone loss. Mitigation strategies include:

  • Co-transformation with a helper plasmid (e.g., pBAD33) to provide additional selectable markers or stability functions.
  • Using low-copy-number vectors (e.g., pBACe3.6) to reduce metabolic burden.
  • Screening for toxicity via colony PCR or sequencing before large-scale propagation.
  • Low Transformation Efficiency
    Poor transformation efficiency can stem from degraded DNA, inefficient ligation, or host strain limitations. Key improvements include:

  • Purifying DNA using agarose gel electrophoresis to remove small fragments and contaminants.
  • Optimizing ligation ratios (e.g., 3:1 insert-to-vector molar ratio) to enhance insert uptake.
  • Using electrocompetent cells prepared with high efficiency (e.g., >1 × 10^9 CFU/µg).
  • Screening and Verification of BAC Clones

    Verification of BAC clones is essential to confirm insert size, integrity, and absence of chimerism. Standard techniques include colony PCR, pulsed-field gel electrophoresis (PFGE), and fluorescence in situ hybridization (FISH), each providing distinct advantages for quality control.

    Colony PCR for Insert Verification
    Colony PCR amplifies a region of the insert using vector-specific primers (e.g., T7 or SP6) or insert-flanking primers. This method rapidly identifies clones containing the target insert but may fail for large inserts (>50 kb) due to PCR limitations. Blockquote:
    "For reliable results, use high-fidelity polymerases (e.g., Phusion) and optimize annealing temperatures to avoid nonspecific amplification."

    Pulsed-Field Gel Electrophoresis (PFGE) for Insert Sizing
    PFGE separates BAC DNA by size, allowing precise determination of insert length. Clones are grown overnight in LB with chloramphenicol, and genomic DNA is prepared in agarose plugs. After digestion with a rare-cutting enzyme (e.g., NotI), fragments are resolved on a 1% agarose gel using a CHEF mapper. Key considerations:

  • Plug preparation must minimize shearing; use low-melting-point agarose and gentle handling.
  • Lambda ladder concatemers serve as molecular weight standards for accurate sizing.
  • Fluorescence In Situ Hybridization (FISH) for Structural Validation
    FISH maps the insert within the BAC vector using fluorescently labeled probes targeting specific genomic regions. This technique detects chimerism, deletions, or rearrangements by comparing probe hybridization patterns to expected genomic loci. Blockquote:
    "FISH requires high-quality probes (e.g., BAC DNA labeled with dUTP) and optimized hybridization conditions (e.g., 70% formamide, 37°C)."

    Reagents and Equipment for BAC Cloning

    The successful construction of a BAC library requires specialized reagents and equipment, summarized below in a structured table for reference.
    Category Item Purpose Notes
    Enzymes BamHI Partial digestion of genomic DNA (6-bp recognition site). Use high-fidelity variants (e.g., BamHI-HF) to reduce star activity.
    NotI Rare-cutting enzyme for PFGE analysis (8-bp recognition site). Optimal

    what is bacterial artificial chromosome - Ilustrasi 3

    Bacterial Artificial Chromosomes in Synthetic Biology and Industrial Applications

    Bacterial artificial chromosomes (BACs) serve as versatile platforms in synthetic biology by enabling the stable propagation and precise manipulation of large DNA segments, including entire metabolic pathways. Their capacity to accommodate inserts exceeding 300 kb makes them ideal for reconstructing complex biosynthetic routes, optimizing microbial chassis for industrial production, and integrating multiple genes under native or engineered regulatory control. Industrial applications leverage BACs to enhance yield, reduce production costs, and improve the scalability of bio-based manufacturing, from biofuels to pharmaceuticals and genetically modified crops.

    The integration of BACs into synthetic biology workflows facilitates the assembly of artificial chromosomes that mimic or exceed natural genomic complexity. This approach allows researchers to engineer microorganisms with tailored metabolic capabilities, such as enhanced substrate utilization, resistance to inhibitory byproducts, or directed flux toward high-value compounds. Below are key areas where BACs drive innovation in industrial biotechnology, supported by structural and functional design principles.

    Engineering BACs for Synthetic Biology

    The design of BAC-based synthetic chromosomes involves modular assembly of genetic elements, including promoters, coding sequences, and regulatory motifs, to achieve predictable metabolic outcomes. Key strategies include:
  • Pathway compartmentalization: Isolating biosynthetic modules within BACs to prevent crosstalk with host metabolism, often using orthogonal replication origins (e.g., pSC101 or p15A) and selectable markers.
  • Regulatory fine-tuning: Employing inducible promoters (e.g., PBAD, PT7) or synthetic riboswitches to balance enzyme expression and minimize metabolic burden.
  • Chassis optimization: Selecting microbial hosts (e.g., Escherichia coli, Bacillus subtilis, or Pseudomonas putida) based on native metabolic compatibility, stress tolerance, and compatibility with BAC replication systems.
  • Design Principle: A synthetic BAC for metabolic engineering should prioritize (1) genetic stability (minimizing recombination or loss of large inserts), (2) orthogonal control (avoiding interference with host pathways), and (3) scalability (compatibility with high-throughput cloning and fermentation).
    The assembly of BACs for synthetic biology often employs Gibson assembly, yeast recombinational cloning (YAC), or transposon-mediated insertion to stitch together multi-gene cassettes. For example, a BAC designed for ethanol production might include:
  • A Zymomonas mobilis pyruvate decarboxylase (pdc) and alcohol dehydrogenase (adhB) operon for direct conversion of glucose to ethanol.
  • A Saccharomyces cerevisiae hexose transporter (HXT) to enhance sugar uptake.
  • A Bacillus subtilis phosphoketolase (xpk) pathway to bypass the glycolytic bottleneck.
  • Industrial Applications of BACs

    BACs enable the production of high-value compounds by consolidating multi-gene pathways into single, stable vectors. Below are prominent industrial sectors where BACs provide a competitive advantage.

    Biofuel Production

    BACs streamline the engineering of microbial cell factories for advanced biofuels, particularly those requiring complex carbon flux redirection. Examples include:

    - Ethanol and Butanol:

  • Strain Engineering: A BAC in E. coli was used to integrate the Clostridium acetobutylicum butanol pathway (comprising thl, hbd, crt, bcd, etfA/B, and adhE2), achieving titers of 15 g/L butanol from glucose (Atsumi et al., 2008).
  • Substrate Flexibility: BACs enable the incorporation of lignocellulosic degradation pathways (e.g., Cel5A, BglA) into P. putida for direct conversion of cellulose to biofuels.
  • - Isobutanol and Fatty Acid Ethyl Esters (FAEEs):

  • Pathway Integration: A synthetic BAC in E. coli combined the isobutanol pathway (ilvCD, kivd, adhA) with a wax ester synthase (WES) for FAEE production, yielding 1.2 g/L of isobutanol-derived esters (Peralta-Yahya et al., 2012).
  • Key Advantage: BACs allow the co-expression of multiple enzymes with native stoichiometry, reducing the need for balanced gene dosage adjustments seen in plasmid-based systems.

    Pharmaceutical Biosynthesis

    The production of recombinant proteins and secondary metabolites via BACs addresses challenges such as low yield, protein aggregation, and host toxicity. Notable applications include:

    - Insulin and Monoclonal Antibodies:

  • Stable Expression: A BAC in Pichia pastoris was engineered to produce human insulin with glycosylation patterns identical to mammalian cells, achieving 5 g/L yields (Cregg et al., 2000).
  • Post-Translational Modifications: BACs in Nicotiana benthamiana enable plant-based antibody production (e.g., therapeutic mAbs) with complex glycosylation profiles, reducing immunogenicity risks.
  • - Antibiotics and Polyketides:

  • Pathway Rewiring: A BAC in Streptomyces was used to redirect the native erythromycin pathway toward the production of the semi-synthetic antibiotic azithromycin by introducing a P450 hydroxylase (McDaniel et al., 2016).
  • Combinatorial Biosynthesis: BACs facilitate the assembly of hybrid polyketide synthase (PKS) modules to generate novel antibiotics (e.g., fusion of rapamycin and FK506 PKS domains).
  • Genetically Modified Crops

    BACs enhance crop improvement by enabling the precise insertion of agronomic traits without random genomic integration. Applications include:

    - Drought and Salt Tolerance:

  • Gene Stacking: A BAC in Arabidopsis thaliana combined a P5CS (proline biosynthesis) and NHX1 (sodium/proton antiporter) pathway to improve salt tolerance under osmotic stress (Zhu, 2001).
  • Epigenetic Stability: BACs reduce position effects by integrating transgenes into euchromatin regions, ensuring consistent expression across generations.
  • - Nutritional Enhancement:

  • Vitamin A (Beta-Carotene) Biosynthesis: A BAC in Golden Rice incorporated psy (phytoene synthase) and crtI (phytoene desaturase) genes from Erwinia uredovora and Pantoea ananatis, increasing provitamin A levels by 23-fold (Ye et al., 2000).
  • Safety Consideration: BAC-based transgenesis minimizes off-target effects by confining foreign DNA to designated genomic "safe harbors," reducing risks of horizontal gene transfer or unintended phenotypic changes.

    Metabolic Engineering with BACs: Pathway Reconstruction and Optimization

    The large insert capacity of BACs (100–300 kb) allows the reconstruction of entire metabolic networks, including:
  • Native Pathway Rescue: Reintroducing disrupted pathways (e.g., lysine or tryptophan biosynthesis) into industrial strains via BACs to restore prototrophy and improve growth.
  • Non-Native Pathway Integration: Combining orthogonal pathways (e.g., E. coli glycolysis with S. cerevisiae ethanol pathway) to create hybrid metabolic chassis.
  • Co-Factor Engineering: Balancing redox co-factors (NADPH/NADH) by co-expressing transhydrogenases or flavodoxins within BACs to prevent metabolic imbalances.
  • Example Workflow for BAC-Based Pathway Design:
    1. Gene Mining: Identify candidate enzymes from metagenomic or synthetic databases (e.g., KEGG, MetaCyc).
    2. Module Assembly: Clone genes into a BAC backbone with compatible promoters (e.g., J23119 for E. coli).
    3. In Silico Modeling: Simulate flux distribution using tools like COBRApy or OptFlux to predict bottlenecks.
    4. Prototyping: Test BAC constructs in high-throughput screens (e.g., 96-well plate assays) before scale-up.

    Visualization of BAC-Based Synthetic Pathways

    A descriptive prompt for illustrating a BAC-encoded metabolic pathway includes:

    - Metabolic Intermediates:

  • Represent intermediates as nodes in a flowchart, annotated with chemical structures (e.g., SMILES notation) and concentrations (if quantified).
  • Color-code intermediates by class (e.g., sugars = green, amino acids = blue, cofactors = orange).
  • - BAC-Encoded Enzymes:

  • Depict enzymes as rectangular blocks labeled with EC numbers (e.g., *EC 1.1.1

    Bacterial Artificial Chromosomes have cemented their status as indispensable tools in genomics, biotechnology, and synthetic biology, bridging the gap between theoretical genetic research and practical industrial applications. From demystifying the human genome to engineering microbial factories for pharmaceutical production, their ability to handle large, stable DNA fragments has redefined experimental boundaries. As advancements in CRISPR and metabolic engineering continue to demand precision at scale, BACs remain a foundational platform—one that merges biological complexity with technological innovation to address challenges in medicine, agriculture, and energy sustainability.

  • FAQ

    What is a BAC, or bacterial artificial chromosome?

    A bacterial artificial chromosome (BAC) is a DNA construct used in molecular biology to clone large DNA fragments (up to ~300 kb) in E. coli. It combines bacterial DNA sequences with a cloning vector to maintain stability and allow high-efficiency transformation. BACs are widely used in genome sequencing, gene mapping, and functional genomics due to their ability to carry large inserts with minimal rearrangement.

    What is the difference between a bacterial artificial chromosome (BAC) and a yeast artificial chromosome (YAC)?

    A bacterial artificial chromosome (BAC) is a cloning vector based on the E. coli F-factor plasmid, stable in bacteria and capable of carrying ~100–300 kb inserts. A yeast artificial chromosome (YAC) mimics natural yeast chromosomes and can hold much larger inserts (~1 Mb or more), but it requires yeast (Saccharomyces cerevisiae) for propagation and is prone to recombination errors. BACs are simpler and more widely used for routine cloning, while YACs are reserved for very large DNA fragments.

    How do you create a bacterial artificial chromosome?

    To make a BAC, start with a vector containing a bacterial origin of replication, antibiotic resistance genes, and cloning sites. The target DNA is fragmented (e.g., via partial digestion or shearing) and ligated into the vector. The recombinant BACs are transformed into E. coli (often E. coli DH10B or similar strains), selected via antibiotic resistance, and verified by colony PCR or restriction analysis. Proper host strains minimize recombination and maintain insert stability.

    What are artificial chromosomes, and what are their types?

    Artificial chromosomes are engineered DNA molecules designed to mimic natural chromosomes, allowing the cloning of large DNA fragments. Types include bacterial artificial chromosomes (BACs), yeast artificial chromosomes (YACs), human artificial chromosomes (HACs), and P1-derived artificial chromosomes (PACs). Each varies by host organism, insert size capacity, and stability, with applications ranging from genome research to synthetic biology.

    Are bacterial chromosomes naturally circular?

    Yes, most bacterial chromosomes are circular double-stranded DNA molecules, unlike eukaryotic chromosomes, which are linear. The circular form allows efficient replication and segregation during cell division. Some bacteria also carry smaller circular plasmids, which are separate from the chromosomal DNA but replicate independently. Exceptions exist, such as Borrelia species, which have linear chromosomes.

    Leave a Comment

    Comments are moderated before appearing. The data you submit is processed according to the Privacy Policy of Voltefac.